FDA Grants 510(k) Clearance to Liver Attenuation AI Software HealthFLD
HealthFLD, a fully automated AI software for liver attenuation analysis from CT scans, has received FDA 510(k) clearance for use in the general population.
Source: hcplive.com
Promising Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Promising Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Promising Phase Today - Breaking & Trending Today
Stephen Harrison, MD: Resmetirom Could Address 'Monumental' Unmet Need in NASH
Stephen Harrison, MD, provides insight into the use of resmetirom for NASH with fibrosis ahead of the thyroid hormone receptor-β selective agonist’s March 14 PDUFA date.
Source: hcplive.com
Protagonist Therapeutics-Janssen Partnered Psoriasis Candidate Fall Short Of Rival Treatment
Protagonist Therapeutics Inc (NASDAQ:PTGX) announced topline results from the Phase 2b FRONTIER 1 trial of the oral interleukin-23 receptor (...
Source: businessinsider.com
Neurimmune: Promising Phase 1 Results For Antibody NI006 In ATTR Cardiomyopathy
Results also presented during late-breaking session at ESC Heart Failure congress 2023 ZURICH, SWITZERLAND, May 22, 2023 - (ACN Newswire) - Neurimmune announced today that primary results of its Phase 1 proof-of-concept study of NI006, a recombinant ...
Source: scoop.co.nz
Neurimmune: Promising Phase 1 Results for Antibody NI006 in ATTR Cardiomyopathy ...
Neurimmune: Promising Phase 1 Results for Antibody NI006 in ATTR Cardiomyopathy ...
Source: pr-inside.com